Residual gastric contents (RGC) Although the overwhelming majority of articles assessed have accepted that GLP-1 RAs can significantly increase residual gastric contents by delaying gastric emptying time as scientific fact, not all have retained this belief
Increases in both proinflammatory cytokines and oxidative and nitrosative stress by activation of microglia via TLR3 could lead to increased IDO activity in microglia, resulting in reduced tryptophan levels, increased kynurenine catabolites, and decreased 5-HT and melatonin synthesis
That same limit applies across the FDA peptide vote 2026: a favorable tally becomes part of the agency record, while a later FDA action determines the operative policy
However, it is still important to monitor mild or moderate symptoms
1 Reports indicate that a shortage of GLP-1 drugs began in late 2022 and has continued well into 2024, in varying durations for various doses of the US Food and Drug Administration (FDA)-approved medications
Fifteen amino acids arranged in a precise sequence that mirrors the body natural gastric protective protein